Trials / Not Yet Recruiting
Not Yet RecruitingNCT07521241
A Clinical Trial to Evaluate the Pharmacokinetics and Safety of AD-230 in Healthy Adults
A Randomized, Open-label, Two-treatment, Two-period, Two-sequence Crossover Clinical Trial to Evaluate the Pharmacokinetics and Safety of AD-230 in Healthy Adults
- Status
- Not Yet Recruiting
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 52 (estimated)
- Sponsor
- Addpharma Inc. · Industry
- Sex
- All
- Age
- 19 Years – 64 Years
- Healthy volunteers
- Accepted
Summary
A Clinical Trial to Evaluate the Pharmacokinetics and Safety of AD-230 in Healthy Adults
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | AD-230, AD-2301 | Oral administration of AD-230 or AD-2301, according to randomized sequence. |
Timeline
- Start date
- 2026-05-01
- Primary completion
- 2026-06-01
- Completion
- 2026-07-01
- First posted
- 2026-04-09
- Last updated
- 2026-04-13
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT07521241. Inclusion in this directory is not an endorsement.